Research Study of ATG and Rituximab in Renal Transplantation
Status:
Terminated
Trial end date:
2017-08-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is see if a combination of two drugs, (ATG and rituximab), given at
the time of the transplant surgery, will help reduce or eliminate the need for long term
immunosuppressive medication.
Phase:
Early Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)